Cerence announces second quarter fiscal year 2024 results

Headlines q2 revenue above the high end of the guidance range due to oem-related adjustments; however, company lowering its fy24 guidance and withdrawing its multi-year plan included in q2 results is a goodwill impairment charge of approximately $252 million company believes that initial success with new generative ai products, including six design wins, and early validation of its next-gen platform will provide a solid foundation to reinvigorate future growth burlington, mass., may 09, 2024 (globe newswire) -- cerence inc. (nasdaq: crnc), ai for a world in motion, today reported its second quarter fiscal year 2024 results for the quarter ended march 31, 2024.
CRNC Ratings Summary
CRNC Quant Ranking